标题/作者	年份
Coronavirus disease 2019: Tinjauan literatur terkini A Susilo, CM Rumende, CW Pitoyo, WD Santoso, M Yulianti, ... Jurnal penyakit dalam Indonesia 7 (1)	2020
Long covid—mechanisms, risk factors, and management H Crook, S Raza, J Nowell, M Young, P Edison bmj 374	2021
COVID-19 pandemic, coronaviruses, and diabetes mellitus R Muniyappa, S Gubbi American Journal of Physiology-Endocrinology and Metabolism	2020
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 W Ni, X Yang, D Yang, J Bao, R Li, Y Xiao, C Hou, H Wang, J Liu, D Yang, ... Critical Care 24 (1), 1-10	2020
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection S Beyerstedt, EB Casaro, ÉB Rangel European journal of clinical microbiology & infectious diseases 40, 905-919	2021
Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications DJ Drucker Endocrine reviews 41 (3), bnaa011	2020
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19) Y Zhou, J Chi, W Lv, Y Wang Diabetes/metabolism research and reviews 37 (2), e3377	2021
Impact of the Coronavirus (COVID-19) pandemic on surgical practice-Part 2 (surgical prioritisation) A Al-Jabir, A Kerwan, M Nicola, Z Alsafi, M Khan, C Sohrabi, N O'Neill, ... International journal of surgery 79, 233-248	2020
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ... Nature metabolism 3 (2), 149-165	2021
The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper SP Stawicki, R Jeanmonod, AC Miller, L Paladino, DF Gaieski, AQ Yaffee, ... Journal of global infectious diseases 12 (2), 47	2020
Global pandemics interconnected—obesity, impaired metabolic health and COVID-19 N Stefan, AL Birkenfeld, MB Schulze Nature Reviews Endocrinology 17 (3), 135-149	2021
Pathophysiological mechanisms of liver injury in COVID‐19 AD Nardo, M Schneeweiss‐Gleixner, M Bakail, ED Dixon, SF Lax, ... Liver International 41 (1), 20-32	2021
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities N Zamorano Cuervo, N Grandvaux elife 9, e61390	2020
Pathophysiology of COVID-19: mechanisms underlying disease severity and progression MK Bohn, A Hall, L Sepiashvili, B Jung, S Steele, K Adeli Physiology 35 (5), 288-301	2020
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature metabolism 3 (6), 774-785	2021
Liver injury in COVID-19: The current evidence SA Alqahtani, JM Schattenberg United European gastroenterology journal 8 (5), 509-519	2020
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19 KP Patel, PA Patel, RR Vunnam, AT Hewlett, R Jain, R Jing, SR Vunnam Journal of Clinical Virology 128, 104386	2020
Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2 F Salamanna, M Maglio, MP Landini, M Fini Frontiers in medicine 7, 594495	2020
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry C Wei, L Wan, Q Yan, X Wang, J Zhang, X Yang, Y Zhang, C Fan, D Li, ... Nature metabolism 2 (12), 1391-1400	2020
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis M Rotondi, F Coperchini, G Ricci, M Denegri, L Croce, ST Ngnitejeu, ... Journal of endocrinological investigation 44, 1085-1090	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。